{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-026286","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.894812+00:00","generated_at":"2026-05-17T14:22:38.566698+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DiaMedica enters $100M ATM equity distribution agreement with TD Cowen","bullets":["Up to $100M in common shares may be sold through TD Cowen as sales agent.","TD Cowen earns up to 3.0% commission on gross proceeds from ATM sales.","Sales cannot occur until the related Form S-3 shelf registration is declared effective.","Proceeds use not specified; agreement includes customary indemnification provisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-026286","json":"https://secwatch.observer/filing/0001437749-25-026286.json","markdown":"https://secwatch.observer/filing/0001437749-25-026286.md","text":"https://secwatch.observer/filing/0001437749-25-026286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925026286/0001437749-25-026286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925026286/dmtp20250812_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:22:38.566698+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}